LOS ANGELES - TelAve -- A noninvasive technology could significantly benefit women diagnosed with breast cancer shares the American Association for Critical Illness Insurance.

One in eight U.S. women (about 12%) will develop invasive breast cancer over the course of her lifetime shares Jesse Slome, director of the American Association for Critical Illness Insurance.  "In 2020, an estimated 276,480 women will be diagnosed with invasive breast cancer. An additional 48,530 new cases of non-invasive (in situ) breast cancer will be diagnosed," Slome notes.

Researchers at Tel Aviv University announced development of a technique that improves gene delivery into breast cancer cells. The technique combines ultrasound with tumor-targeted microbubbles.

"Microbubbles are microscopic bubbles filled with gas," explains Dr. Tali Ilovitsh who led the research team.  This process increases the transfer of substances from the blood vessels into the surrounding tissue.  The researchers injected them directly into tumors in a mouse model.  About 80% of tumor cells were destroyed.

More on TelAve News

• 3E Launches First AI Agent Designed to Respond with Empathy for College Recruitment
• Security Alert: TZNXG Warns Investors About "Fund Recovery" Scams
• Assent Unveils Extended Producer Responsibility Packaging Solution to Simplify Compliance with Expanding Packaging Laws
• KatalisCoin: "Too Secure" for Bad Actors - Platform Embraces "Excessive Compliance" Criticism
• Keyanb Exchange Implements Enhanced Security Protocols Amid Industry-Wide Trust Challenges

The report in Proceedings of the National Academy of Sciences of the United States notes that membrane pores were formed in the remaining 20% of the cancer cells. This triggered an immune response that destroyed the cancer cells.

The critical illness insurance expert shared some data regarding breast cancer.  "For women under age 45 breast cancer is more common in Black women than white women," Slome explained.  Among Asian, Hispanic, and Native-American women, the risk of developing and dying from breast cancer is lower. Ashkenazi Jewish women have a higher risk of breast cancer because of a higher rate of BRCA mutations.

"Women must understand their real risk. In addition to examinations, planning is vital for the financial consequences associated with a breast cancer diagnosis," shares Slome.

Women will find their health insurance doesn't cover every dollar of costs. And taking off from their jobs to undergo treatments often means reduced income." A modest cancer insurance policy can cover healthcare costs," Slome advises. "Use it to replace lost income while you undergo treatment and recovery time. It's vital for women age 40 and older to consider."  For more information visit the association's website at https://www.criticalillnessinsuranceinfo.org or call 818-597-3205.

More on TelAve News

• TSWHZC Platform Combines Automated Portfolio Management with Proof of Reserves for Brazil Market Entry
• AureaVault Positions Digital Asset Infrastructure for Shifting Monetary Policy Environment
• JQRBT Unveils High-Speed Trading Infrastructure Designed for Growing Institutional Crypto Market
• New Leadership and Renovations Usher in Next Chapter for Sunrise Manor
• Who Will Win the 2025 WNBA Finals? OddsTrader Shares Live Betting Odds and Projections

To read ways to find the best critical illness insurance, go to https://criticalillnessinsuranceinfo.org/best-critical-illness-insurance/.